Related Experiment Video
Updated: Aug 1, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
The roles of FHL2 in cancer
Jiawei Zhang1, Qun Zeng1, Meihua She2
1Department of Biochemistry and Molecular Biology, Hengyang Medical School, University of South China, Changsheng West Road 28, Hengyang, 421001, China.
Abstract:
LIM domain protein 2, also known as LIM protein FHL2, is a member of the LIM-only family. Due to its LIM domain protein characteristics, FHL2 is capable of interacting with various proteins and plays a crucial role in regulating gene expression, cell growth, and signal transduction in muscle and cardiac tissue. In recent years, mounting evidence has indicated that the FHLs protein family is closely associated with the development and occurrence of human tumors. On the one hand, FHL2 acts as a tumor suppressor by down-regulating in tumor tissue and effectively inhibiting tumor development by limiting cell proliferation. On the other hand, FHL2 serves as an oncoprotein by up-regulating in tumor tissue and binding to multiple transcription factors to suppress cell apoptosis, stimulate cell proliferation and migration, and promote tumor progression. Therefore, FHL2 is considered a double-edged sword in tumors with independent and complex functions. This article reviews the role of FHL2 in tumor occurrence and development, discusses FHL2 interaction with other proteins and transcription factors, and its involvement in multiple cell signaling pathways. Finally, the clinical significance of FHL2 as a potential target in tumor therapy is examined.
Insights
LIM protein FHL2 has dual roles in cancer, acting as both a tumor suppressor and an oncoprotein. Its complex functions in gene regulation and cell signaling highlight its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- LIM domain protein 2 (FHL2) is a member of the LIM-only protein family.
- FHL2 interacts with various proteins, regulating gene expression, cell growth, and signal transduction, particularly in muscle and cardiac tissues.
- The FHLs protein family is increasingly linked to human tumor development.
Purpose of the Study:
- To review the multifaceted role of FHL2 in tumor occurrence and progression.
- To discuss FHL2's interactions with proteins and transcription factors.
- To examine the clinical significance of FHL2 as a potential cancer therapeutic target.
Main Methods:
- Literature review of FHL2's function in cancer.
- Analysis of FHL2's interactions with other molecules.
- Examination of FHL2's involvement in cellular signaling pathways.
Main Results:
- FHL2 exhibits a "double-edged sword" role in tumors, acting as both a tumor suppressor and an oncoprotein.
- As a tumor suppressor, FHL2 is down-regulated and inhibits tumor development by limiting cell proliferation.
- As an oncoprotein, FHL2 is up-regulated, promoting tumor progression by suppressing apoptosis and stimulating proliferation and migration.
Conclusions:
- FHL2 possesses complex and independent functions in tumor development.
- Understanding FHL2's interactions and signaling pathways is crucial.
- FHL2 represents a promising, albeit complex, target for future cancer therapies.
Related Concept Videos
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Hedgehog Signaling Pathway
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Regulation of Angiogenesis and Blood Supply

